Obinutuzumab administration

DRUG2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Radboud University Medical Center

Conditions

Lupus NephritisMembranous Nephropathy - PLA2R InducedSystemic Lupus Erythematosus (SLE)

Phase 2

Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot Study

RecruitingNCT07163611

Radboud University Medical CenterMembranous Nephropathy - PLA2R Induced

Start: 2025-10-01End: 2028-04-01Target: 20Updated: 2026-01-06

Phase 3

Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

RecruitingNCT04702256

Assistance Publique - Hôpitaux de ParisLupus Nephritis, Systemic Lupus Erythematosus (SLE)

Start: 2021-12-09End: 2031-12-31Target: 196Updated: 2025-11-24

Related Papers

Étude des points de tolérance et du rôle de BAFF lors de la reconstitution lymphocytaire B au cours du lupus systémique

La Revue de Médecine Interne2023-11-27